Phosphorylation/inactivation of RB is typically required for cell cycle progression. However, we have identi®ed a tumor cell line, C33A, which progresses through the cell cycle in the presence of an active allele of RB (PSM-RB). To determine how C33A cells evade RB-mediated arrest, we compared RB signaling to downstream eectors in this resistant cell line to that of the RBsensitive SAOS-2 cell line. Although introduction of PSM-RB repressed E2F-mediated transcription in both C33A and SAOS-2 cells, PSM-RB failed to repress Cyclin A promoter activity in C33A. Ectopic expression of PSM-RB in SAOS-2 cells resulted in a decrease in both Cyclin A and Cdk2 protein levels without aecting Cyclin E or Cdk4. In contrast, over-expression of PSM-RB in C33A cells did not alter endogenous Cyclin A, Cyclin E, or Cdk2 protein levels or impact Cdk2 kinase activity, indicating that signaling from RB to downstream targets is abrogated in this cell line. The importance of Cdk2 activity was demonstrated by p27Kip1, which attenuated Cdk2 activity and inhibited cell cycle progression in C33A cells. Since RB signaling to Cdk2 is disrupted in these tumor cells, we coexpressed two proteins that cooperate with RB in transcriptional repression, AHR and BRG-1, in an attempt to correct this signaling dysfunction. Coexpression of AHR/BRG-1 with PSM-RB attenuated Cyclin A and Cdk2 expression as well as Cdk2-associated kinase activity, resulting in cell cycle inhibition of C33A cells. Importantly, ectopic expression of Cyclin A was able to reverse the arrest mediated by co-expression of AHR/BRG-1 with PSM-RB. These results indicate that down-regulation of Cdk2 activity is requisite for RB-mediated cell cycle arrest. Thus, this study reveals a new mechanism through which tumor cells evade anti-proliferative signals, and provides insight into how RB-signaling is mediated.
Introduction
The retinoblastoma protein (RB) is the prototypical tumor suppressor Sherr, 1996; Wang et al., 1994) . The importance of RBdependent anti-proliferative activity is emphasized by the observation that RB is inactivated in greater than 60% of human tumors, through both direct and indirect mechanisms Sellers and Kaelin, 1997; Sherr, 1996) . RB-mediated tumor suppression is believed to involve the cell-cycle inhibitory action of RB. Through direct binding, RB assembles speci®c protein complexes that act to inhibit cell cycle transitions. For example, the E2F family of transcription factors, which activate genes responsible for initiation of S phase, are critical downstream targets of RB (Dyson, 1998; Weinberg, 1995) . Once bound to E2F, RB recruits histone deacetylase (HDAC), thus converting E2F from a transcriptional activator to a transcriptional repressor (Brehm et al., 1998; DePhino, 1998; Magnaghi-Jaulin et al., 1998; Sidle et al., 1996; Wang et al., 1994; Weinberg, 1995; Xiao et al., 1995; Zhang et al., 1999) . Since the ability of RB to interact with speci®c cellular proteins is vital to its role as a cell cycle inhibitor, it is not surprising that disruption of RB protein binding capabilities is a common event in human tumors. Speci®cally, it has been shown that RB is functionally inactivated via: (i) mutation at the chromosomal level; (ii) overt phosphorylation due to the deregulated expression of proteins that phosphorylate RB; and (iii) inactivation by the direct binding of oncoproteins of DNA tumor viruses (e.g. E7 of the high risk human papilloma virus (HPV)) Bartkova et al., 1997; Reed, 1997; Sellers and Kaelin, 1997; Weinberg, 1995) . In theory, tumor cells could also abrogate the signaling pathway to downstream eectors of RB as a mechanism to evade RB-mediated growth arrest.
Cell cycle progression under normal growth conditions requires that RB becomes inactivated by Cyclin dependent kinase (Cdk) catalyzed phosphorylation, which occurs in response to mitogenic stimuli Bartkova et al., 1997; Sherr, 1996) . Mitogens stimulate Cyclin D/Cdk4 activity, which then initiates phosphorylation and subsequent inactivation of RB. It is believed that the Cyclin D/Cdk4 complex acts principally to phosphorylate RB, since the Cyclin D/Cdk4 inhibitor, p16ink4a, or injection of anti-Cyclin D antibodies does not inhibit cell cycle progression in RB de®cient cells (Koh et al., 1995; Lukas et al., 1995a,b; Medema et al., 1995) . In addition to Cyclin D/Cdk4, Cdk2 activity is implicated in phosphorylating and inactivating RB in late G1 . Cdk2 associates with both Cyclin A and Cyclin E and it has been shown that these two complexes are both required and rate limiting for progression into S phase (Ohtsubo et al., 1995; Resnitzky et al., 1994) . Phosphorylation inactivates RB, via disruption of its protein binding abilities. Thus, E2F is derepressed and activates the transcription of a variety of genes responsible for S phase Dyson, 1998; Nevins et al., 1997) .
Reintroduction of wild-type RB into various tumorigenic and non-tumorigenic cells is ineective at inhibiting cellular proliferation, since the protein is rapidly inactivated by endogenous Cdk activity (Knudsen and Wang, 1997; Knudsen et al., 1998; Lukas et al., 1997) . To circumvent RB-phosphorylation and thereby study the in¯uence of active RB, we generated a phosphorylation site mutant of RB (PSM-RB) that renders it resistant to Cdk-mediated inactivation (Knudsen and Wang, 1997) . This constitutively active mutant of RB retains its ability to bind proteins like the transcription factor E2F, regardless of phosphorylation status (Knudsen and Wang, 1997) . In previous studies, it has been shown that expression of PSM-RB invokes cell cycle arrest in almost all cell lines, including those which are not in¯uenced by wildtype RB (Knudsen and Wang, 1997; Knudsen et al., 1998; Lukas et al., 1997 Lukas et al., , 1999 . In PSM-RB arrested cells, both Cyclin A expression and Cdk2 associated kinase activity are attenuated (Alevizopoulos et al., 1997; Knudsen et al., 1998 Knudsen et al., , 1999a Lukas et al., 1999) . Interestingly, Cyclin E expression is never attenuated in such arrested cells, which is surprising since Cyclin E is an E2F-regulated gene (Alevizopoulos et al., 1997; Knudsen et al., 1998 Knudsen et al., , 1999a Lukas et al., 1999) . The down-regulation of Cyclin A is of functional importance, as ectopic expression of Cyclin A can overcome PSM-RB induced cell cycle arrest (Knudsen et al., 1999a; Meraldi et al., 1999) .
The idea that phosphorylation of RB is an absolute requirement for cell cycle progression was challenged, however, by the recent ®nding that expression of constitutively active RB does not universally inhibit cell cycle progression (Knudsen et al., 1999b) . We have previously shown that ectopic expression of PSM-RB does not inhibit cell cycle progression in the RBde®cient, HPV negative, cervical carcinoma cell line, C33A (Knudsen et al., 1999b; Schener et al., 1991) . We hypothesized that a novel mechanism must exist that renders these cells resistant to RB-mediated cell cycle arrest. One likely hypothesis was that RB signaling to downstream targets is abrogated in C33A cells. Such a signaling defect could represent an additional mechanism through which RB is inactivated during tumorigenesis. Unlike p16ink4a loss or Cyclin D1 over-expression which act upstream of RB, such a defect would eectively inactivate RB by uncoupling it from its downstream signaling pathway. This idea is supported by the prior ®ndings that certain proteins act in cooperation with RB, indicating that loss of such proteins may compromise RB-signaling. For example, it has been reported that the brahma-related gene (BRG-1) can enhance RB-mediated transcriptional repression and perhaps co-mediate RB-induced cell cycle arrest (Dunaief et al., 1994; Kadonaga, 1998; Kingston et al., 1996; Strober et al., 1996; Trouche et al., 1997) . Similarly, the aromatic hydrocarbon receptor (AHR) can also enhance the function of RB as a transcriptional repressor and synergize with RB to induce cell cycle arrest (Ge and Elferink, 1998; Puga et al., 2000) .
In this report, we investigated the mechanism through which tumor cells evade PSM-RB mediated cell cycle inhibition. We found that expression of PSM-RB in both C33A cells, which are resistant to RB, and in SAOS-2 (RB-de®cient osteogenic sarcoma) cells, that are arrested by RB, E2F transcriptional activity was repressed. However, PSM-RB failed to down-regulate Cyclin A promoter activity only in C33A cells. In addition, ectopic expression of active RB in SAOS-2 cells resulted in the down regulation of endogenous Cyclin A and Cdk2 protein while there was no change
Cdk2 is a functional target of RB MW Strobeck et al in the expression of these downstream targets in C33A cells. We show that Cdk2 activity is required for cell cycle progression using the Cdk-inhibitor p27Kip1, suggesting that if RB signaling to Cdk2 could be restored, C33A cells should arrest. Strikingly, coexpression of PSM-RB with AHR and BRG-1 caused the attenuation of Cyclin A and Cdk2 expression along with a reduction in Cdk2 kinase activity resulting in cell cycle arrest. This arrest could be partially alleviated through ectopic co-expression of Cyclin A, suggesting that the down-regulation of Cdk2 activity is causative for the cell cycle inhibition. These data provide the ®rst evidence that disruption of RB signaling to downstream eectors occurs in human tumor cells, and provides a unique system to probe the mechanism through which RB signals to mediate cell cycle arrest.
Results

C33A cells are resistant to constitutively active RB although E2F-activity is repressed
In the majority of cell lines studied, ectopic expression of PSM-RB inhibits cell cycle progression (Knudsen et al., , 1999b Lukas et al., 1997) . This ®nding is consistent with the idea that phosphorylation of RB is required for transition through the cell cycle. However, in the RB-de®cient C33A cervical carcinoma cell line, over-expression of PSM-RB does not inhibit cell cycle progression (Knudsen et al., 1999b) . Consistent with this observation, when PSM-RB and H2B-GFP were co-transfected into the C33A cervical carcinoma cell line, the cells proved to be resistant to the constitutively active allele of RB, as evidenced by their ability to eciently incorporate BrdU (Figure 1a) . The per cent of PSM-RB transfected cells incorporating BrdU was similar to that of vector transfected (GFP positive) and untransfected (GFP negative) cells (Figure 1a) . Consistent with the BrdU data, analysis of the cell cycle distribution by¯ow cytometry revealed that PSM-RB had no signi®cant eect on the cell cycle distribution (data not shown). However, in the SAOS-2 cell line, over-expression of PSM-RB was sucient to cause the inhibition of BrdU incorporation (Figure 1b ), arresting these cells in G1 (data not shown). These results indicate that the C33A tumor cell line does not require the phosphorylation of RB for cell cycle progression. As such, C33A cells provide a unique system with which to study the eects of RB on cell (1 mg), or DHFR (1 mg) promoters, and the indicated expression plasmids: PSM-RB (3 mg), or p27kip1 (3 mg). All transfections were brought to 8 mg total plasmid DNA with the parental vector (CMVNeoBam). Data shown are from at least three independent experiments and were normalized to b-gal activity for transfection eciency. Relative luciferase activity was set to 100% cycle and provide insight into how tumor cells can speci®cally evade the anti-proliferative eects of RB.
Since it is well established that dephosphorylated RB can bind to E2F and repress transcription of E2F target genes, we examined whether expression of PSM-RB in C33A was defective in signaling to an E2F dependent promoter. Previous studies have shown that in cells arrested by PSM-RB, E2F transcriptional activity is repressed (Knudsen et al., 1999a,b; Lukas et al., 1997) . To test this in both RB-resistant cells (C33A) and RB-sensitive cells (SAOS-2) the 3XE2Fluc reporter was utilized, which harbors three binding sites for the E2F transcription factor (Whittaker et al., 1998) . When PSM-RB was transfected into C33A and SAOS-2 cells, transcription from the E2F dependent promoter was repressed by 77% ( Figure 1c ) and 73% (Figure 1d ) respectively. In C33A, ectopic expression of the Cdk-inhibitor p27kip1 had no eect on 3XE2F-Luc activity ( Figure 1c ). To extend these ®ndings, the dihydrofolate reductase promoter (DHFRLuc) was utilized which is a physiological E2F-dependent promoter. These experiments showed that expression of PSM-RB in both C33A and SAOS-2 cells was also sucient to inhibit DHFR-promoter activity (Figure 1c, d) . Expression of p27kip1 in C33A cells had no eect on DHFRLuc and had values similar to that of vector ( Figure 1c ). Thus in the RB-resistant C33A cell line, RB is still eective in inhibiting E2F dependent promoter activity, but this signaling is not sucient for halting cell cycle progression.
PSM-RB fails to inhibit Cdk2 activity in C33A cells
In all cell lines studied, dephosphorylation of RB results in reduced Cdk2 activity and reduced Cyclin A promoter activity (Alevizopoulos et al., 1997; Knudsen et al., 1998; Lukas et al., 1999) . To determine if activated RB expressed in C33A retains these capabilities, we co-transfected the PSM-RB expression plasmid with a human Cyclin A reporter (-608cycA-Luc) plasmid. In contrast to what we previously observed in PSM-RB-responsive cell lines (Knudsen et al., 1999a) , transfection of PSM-RB into C33A cells had no eect on Cyclin A promoter activity, while p27kip1 was capable of inhibiting Cyclin A dependent promoter activity (Figure 2a ). This result is consistent with the prior ®nding that p27kip1 can bind to and directly inhibit Cyclin A promoter activity (Shulze et al., 1996) . In SAOS-2 cells, ectopic expression of PSM-RB was eective at inhibiting Cyclin A dependent promoter activity when compared to vector ( Figure  2b ). Therefore, in C33A cells there is a speci®c defect in transcriptional repression of Cyclin A, but no general defect in E2F activity.
To investigate the in¯uence of RB on endogenous Cdk/Cyclins; C33A and SAOS-2 cells were cotransfected with vector, PSM-RB, or p27kip1 along with a puromycin resistance plasmid (pBABE-puro). After puromycin selection the cells were harvested and subjected to immunoblot analysis. In SAOS-2 cells, ectopic expression of PSM-RB caused a decrease in both endogenous Cyclin A and Cdk2 protein while not aecting Cyclin E or Cdk4 (Figure 2, lanes 1 and 2) . As shown in Figure 2d , expression of PSM-RB in C33A cells had no eect on the levels of endogenous Cyclin A protein, which was similar to vector (lanes 2 and 3). However, transfection of p27kip1 was sucient to inhibit Cyclin A protein expression (Figure 2d , lane 1). C33A cells over expressing vector, PSM-RB or p27kip1 did not demonstrate altered Cdk4 or Cdk2 protein expression. Interestingly, p27kip1 caused an increase in endogenous Cyclin E protein while vector and PSM-RB did not cause this augmentation ( Figure  2d, lane 1) . The ability of p27kip1 to increase Cyclin E is consistent with previous ®ndings (Ciaparrone et al., 1998; Won and Reed, 1996) . Lastly, to determine if RB in¯uenced Cdk2 kinase activity, in vitro kinase reactions were performed. Cdk2 was immunoprecipitated from vector, PSM-RB and p27kip1 transfected C33A cells that had undergone puromycin selection. The Cdk2 complex immunoprecipitated from vector and PSM-RB transfected cell was active as evidenced by its ability to phosphorylate a histone H1 substrate ( Figure 2e , lanes 2 and 4). Cdk2 immunoprecipitated from vector and PSM-RB transfected cells has approximately equal activity when normalized to Cdk2 protein (Figure 2e ). However, Cdk2 immunoprecipitated from p27kip1 expressing cells was inactive, as demonstrated by an inability to eciently phosphorylate histone H1 (Figure 2e , lane 3). These data suggest that RB signaling to downstream targets such as Cyclin A or Cdk2 is disrupted in C33A cells.
Cdk2 kinase activity is required for cell cycle progression in C33A cells
Since RB does not downregulate Cdk2 kinase activity in C33A cells, we sought to determine if this activity is vital for cell cycle progression. Since p27kip1 is eective at inhibiting Cyclin A as well as Cdk2 kinase activity, we hypothesized that p27kip1 over-expression would inhibit cell cycle progression. To test this hypothesis, C33A cells were co-transfected with H2B-GFP and vector, PSM-RB, or p27kip1 and scored for BrdU incorporation. Interestingly, over expression of p27kip1 was eective at reducing BrdU incorporation to 25.3% when compared with vector alone (76.8%) or untransfected (GFP negative) cells (Figure 3a,b) . Thus, down regulation of Cdk2 is sucient to inhibit cell cycle progression and these data suggest that the inability of RB to signal to Cdk2 contributes to the ability of C33A cells to evade RB-mediated cell cycle arrest.
AHR and BRG-1 restore RB signaling to Cdk2 and Cyclin A
The data presented indicate that RB fails to arrest C33A cells because a disruption exists in the signal from RB to Cdk2. In an attempt to reverse this dysfunction, we employed two proteins that are known to cooperate with RB, AHR and BRG-1. Since C33A cells have reduced BRG-1 expression (Dunaief et al., 1994) and lack endogenous AHR protein (data not shown), loss of such cooperating proteins might be one mechanism by which these cells confer resistance to PSM-RB. Therefore, we tested whether either of these two proteins may be able to restore RB-mediated signaling in C33A cells. To do so, C33A cells were transfected with vector, AHR, BRG-1, AHR+PSM-RB (3 : 1 ratio) or BRG-1+PSM-RB (1 : 1 ratio) along with a puromycin resistance plasmid. AHR was Cdk2 is a functional target of RB MW Strobeck et al transfected at a 3 : 1 ratio with PSM-RB based on the report of Puga et al. (2000) . who showed this to be the optimal concentration for cooperation in the arrest in SAOS-2 cells. Co-expression of AHR+PSM-RB or BRG-1+PSM-RB decreased endogenous Cyclin A and Cdk2 expression but not Cyclin E or Cdk4 (Figure 4a , lane 3 and Figure 4b , lane 3). Expression of AHR, BRG-1 or vector alone had no eect on Cyclin E, Cyclin A, Cdk2 or Cdk4 protein expression (Figure 4a lanes 1 and 2 and Figure 4b lanes 1 and 2) . To demonstrate that the eects observed upon co-expression of AHR/BRG-1 with PSM-RB could not be attributed to the ability of AHR or BRG-1 to increase PSM-RB expression, PSM-RB protein levels were monitored. As shown in Figure 4c , co-expression of AHR/BRG-1 with PSM-RB caused no change in PSM-RB protein levels, suggesting that the reduction in Cyclin A and Cdk2 protein was due to the cooperation Figure 4a ,b, AHR/BRG-1 also facilitated the ability of PSM-RB to attenuate Cyclin A promoter activity (Figure 4f ). Thus, AHR and BRG-1 can restore RB signaling to attenuate Cyclin A promoter activity and endogenous Cyclin A/Cdk2 protein.
AHR and BRG-1 cooperate with RB to halt progression from G1-S
To determine whether active RB mediated reduction of Cdk2 activity is important for cell cycle inhibition, C33A cells were co-transfected with H2B-GFP and either vector, AHR, BRG-1, PSM-RB, AHR+PSM-RB (3 : 1 ratio) or BRG-1+PSM-RB (1 : 1 ratio) and scored for BrdU incorporation. Cells transfected with vector, AHR, BRG-1 and PSM-RB incorporated BrdU at approximately equal rates (Figure 5a ). However, the cells co-transfected with AHR+PSM-RB and BRG-1+PSM-RB demonstrated a signi®cant decrease in BrdU incorporation when compared to vector ( Figure  5a ,b). It should be noted that approximately 25% of AHR+PSM-RB and BRG-1+PSM-RB transfected cells maintain a sub-maximal level of BrdU incorporation ( Figure 5c ). Such punctate staining is consistent with restoration of the previously described S phase inhibitory action of RB and these cells were scored as negative Lukas et al., 1999) . Consistent with this eect,¯ow cytometry data revealed a decrease in 4N DNA content with a modest increase in 2N (data not shown). Thus RB-mediated cell cycle arrest can be achieved but only via cooperation with AHR or BRG-1. To determine whether Cyclin A was a functional target in the AHR/BRG-1 and PSM-RB-mediated arrest, Cyclin A was ectopically expressed in the presence of AHR/BRG-1 and PSM-RB ( Figure 6 ). As shown above, the combination of PSM-RB with AHR or BRG-1 was capable of signi®cantly inhibiting BrdU incorporation. The ectopic expression of Cyclin A was able to restore BrdU incorporation, indicating that the down-regulation of Cyclin A contributes to the observed cell cycle inhibition.
Discussion
Abrogation of RB signaling to downstream effectors
In this study, we describe how the C33A tumor cell line evades RB-mediated cell cycle control. We had previously observed that ectopic expression of PSM-RB is not sucient to arrest C33A cells (Knudsen et al., 1999b) , and hypothesized that in this tumor line RB has lost the ability to signal to downstream eectors. E2F is a well-studied target of RB, and it is thought that the ability of RB to repress E2F-transcription is the underlying mechanism through which RB inhibits entry into S phase Dyson, 1998; Nevins et al., 1997; Zhang et al., 1999) . Accordingly, we examined whether ectopic expression of PSM-RB in C33A cells was capable of signaling to E2F-dependent promoters. Interestingly, expression of PSM-RB did result in down regulation of two distinct E2F dependent promoter activities, 3XE2F and DHFR. In fact, fold inhibition of the 3XE2F promoter was approximately the same in cells which failed to arrest by PSM-RB (C33A), and in cells which were eciently cell cycle inhibited (SAOS-2). A previous report has shown that wild-type RB is a more potent repressor of E2F activity in SAOS-2 cells rather than in C33A, but the basis behind this dierence is likely attributed to the fact that wild-type RB is phosphorylated in C33A but not SAOS-2 cells (Trouche et al., 1997; Harbour et al., 1999; Bremner et al., 1995) . Consistent with other reports, our data with PSM-RB indicate that ectopic over-expression of active 6 mg) , and BRG-1 (4.8 mg)+PSM-RB (1.6 mg) as indicated. All transfections were brought to 8 mg total plasmid DNA using blank vector (CMVNeoBam). Data shown are from four independent experiments and were normalized to b-gal activity for transfection eciency RB does eciently repress E2F-dependent transcription in C33A cells (Whittaker et al., 1998; Harbour et al., 1999; Bremner et al., 1995) . Therefore, in C33A cells PSM-RB is able to signal to inhibit E2F promoter activity but this inhibition is not sucient to halt cell cycle progression. Since E2F is known to regulate the expression of the cell cycle regulatory genes Cyclin A, Cyclin E, and Cdk2, we assessed whether over-expression of active RB could alter the expression of these downstream targets in SAOS-2 and C33A cells (Dyson, 1998; Nevins et al., 1997) . Initially, we found that in C33A cells, ectopic expression of PSM-RB does not signal to down-regulate Cyclin A promoter activity. This is in contrast to what we observed in SAOS-2 cells, wherein PSM-RB caused a signi®cant reduction in Cyclin A promoter activity. Furthermore, in all settings where RB-mediates cell cycle arrest, Cyclin A promoter activity was inhibited (Phillips et al., 1998; Knudsen et al., 1999a; Lukas et al., 1999) . These ®ndings suggest that while RB eciently signals to E2F, it is compromised for signaling to other transcriptional targets in C33A cells. To verify these ®ndings and examine additional targets of RB, we analysed the level of endogenous proteins in C33A and SAOS-2 cells following the expression of PSM-RB. In C33A cells there was no detectable change in the level of Cdk4, Figure 6 Ectopic expression of Cyclin A reverses the cell cycle arrest induced by PSM-RB with AHR/BRG-1. C33A cells were seeded onto glass coverslips and were co-transfected with a H2B-GFP-expression plasmid (0.125 mg) and vector (3.875 mg), AHR (1 mg)+PSM-RB (3 mg), BRG-1 (2 mg)+PSM-RB (2 mg), AHR (0.75 mg)+PSM-RB (2.25 mg)+Cyclin A (1.5 mg), BRG-1 (1.3 mg)+PSM-RB (1.3 mg)+Cyclin A (1.3 mg). BrdU was added 48 h post-transfection and cells were ®xed following a 16-h label period. After staining with an anti-BrdU antibody (red) the cells were analysed by indirect immuno-¯uorescence. The displayed values were determined from two or three independent experiments with at least 150 transfected (GFP positive) and untransfected (GFP negative) cells scored per experiment Cdk2, Cyclin E, or Cyclin A proteins following PSM-RB transfection. This contrasts with p27Kip1 expression in C33A cells (using the identical experimental protocol), after which an upregulation of Cyclin E protein levels and a signi®cant decrease in Cyclin A protein levels was observed. These ®ndings are consistent with known eects of p27Kip1 on Cyclin expression, since ectopic expression of p27Kip1 stabilizes Cyclin E protein, thereby leading to enhanced accumulation, while p27Kip1 binds to and directly inhibits Cyclin A promoter activity (Won and Reed, 1996; Schulze et al., 1996) . In contrast with either PSM-RB or p27Kip1 expression in C33A cells, expression of PSM-RB in SAOS-2 cells led to a speci®c reduction in Cyclin A and Cdk2 protein levels. The reduction of Cyclin A levels are consistent with other instances of RB-mediated cell cycle inhibition (Knudsen et al., , 1999a Alevizopoulos et al., 1997; Lukas et al., 1999) . Although Cdk2 is an E2F regulated gene, Cdk2 protein levels have not been previously reported to be down regulated by RB Lukas et al., 1999) . However, we have recently observed that Cdk2 expression is inhibited in immortalized rat cells expressing PSM-RB, albeit with later kinetics than Cyclin A (not shown). Thus Cdk2 likely represents an additional RB target.
Together, the data presented here suggest that the ability of RB to attenuate Cyclin A and Cdk2 expression can be separated from basic E2F-mediated repression. Thus in SAOS-2 cells RB signals to E2F, Cyclin A, and Cdk2 resulting in cell cycle arrest; while in C33A cells RB signals to E2F, but not Cyclin A or Cdk2 and these cells do not arrest.
Reconnecting RB to downstream effectors
RB carries out its growth suppressing function by recruiting cellular proteins and assembling protein complexes Sidle et al., 1996; Wang et al., 1994) . Among the greater than 50 identi®ed RB binding proteins, only BRG-1 and AHR have been shown to be important for cooperating with RB to induce cell cycle arrest (Dunaief et al., 1994; Puga et al., 2000; Strober et al., 1996) . Strikingly, we found that co-expression of PSM-RB with either AHR or BRG-1 resulted in the reduction of Cyclin A and Cdk2 expression but not Cyclin E or Cdk4 proteins in C33A cells. The ®nding that co-expression of BRG-1 or AHR with PSM-RB enabled PSM-RB to inhibit the expression/transcription of Cyclin A, is consistent with what is observed in cell lines arrested by PSM-RB (Alevizopoulos et al., 1997; Knudsen et al., , 1999a Philips et al., 1998) . Interestingly, coexpression of BRG-1 or AHR with PSM-RB also led to RB-mediated inhibition of Cdk2 expression. These ®ndings are consistent with what was observed in SAOS-2 cells, and suggest that the expression of BRG-1 or AHR eectively converts C33A cells into cells properly regulated by RB. It is interesting that in all cells which are sensitive to RB mediated arrest, Cyclin E expression is never attenuated, despite the fact that Cyclin E is an E2F-regulated gene (Knudsen et al., , 1999 Lukas et al., 1999) . As such, the mechanism through which these speci®c E2F-regulated genes are targeted for transcriptional repression by RB remains unclear. However, our ®ndings would indicate that the presence of RB alone does not mandate repression, and at least the repression of Cyclin A can be achieved via the co-expression of BRG-1 and AHR.
The mechanism by which AHR and BRG-1 allow for this RB-dependent repression of speci®c targets is yet unresolved. One possibility is that AHR or BRG-1 could enhance RB signaling by bringing RB to promoters that are not accessible to E2F. Consistent with this notion, Murphy et al. (1999) discovered a role for BRG-1 in negatively regulating the c-fos promoter. Speci®cally, it was shown in C33A cells that repression of the c-fos gene by BRG-1 was RB-dependent but E2F-independent (Murphy et al., 1999) . Another possibility is that AHR or BRG-1 can increase the association between RB and E2F, making it a more potent repressor of physiological E2F target genes. Supporting this idea is the observation that both AHR and BRG-1 enhance RB-mediated repression of E2F transcription on synthetic reporters (Puga et al., 2000; Trouche et al., 1997) .
Restoration of RB-mediated arrest
Regardless of RB status, Cdk2 kinase activity is essential for cell cycle progression (Ohstubo et al., 1995) . It has also been shown in previous reports that a RB-mediated G1 arrest results in the reduction of Cdk2 activity (Knudsen et al., , 1999a . However, signaling to reduce Cdk2 activity is abrogated in C33A cells. Apparently the downregulation of Cdk2 is both sucient and required for cell cycle arrest in C33A cells as indicated by the observations that: (i) C33A cells do not undergo an arrest or down regulate Cdk2 in the presence of active RB; (ii) ectopic expression of p27kip1, which downregulates Cdk2 kinase activity, inhibits cell cycle progression; and (iii) over-expression of Cyclin A is sucient to overcome the arrest achieved by RB and BRG-1/AHR co-expression. Together these results show that connecting RB signaling to downstream targets is required and sucient to induce a G1 arrest.
Thus, C33A cells provide a novel system in which to study the mechanism through which RB must function to induce cell cycle arrest, since RB phosphorylation in these cells is not required for cell cycle progression. In C33A cells the dependence of RB on AHR and BRG-1 co-expression to induce cell cycle arrest makes these proteins possible targets for inactivation in cancer. Since AHR is not expressed in SAOS-2 cells (Puga et al., 2000) and these cells are eciently arrested by PSM-RB, apparently AHR is not required for PSM-RB mediated arrest. Importantly, AHR is a tool that can be utilized to enhance RB-mediated transcriptional repression and promote cell cycle inhibition in C33A cells. Our results do not address the requirement for BRG-1, but clearly show that BRG-1 is sucient to cooperate with PSM-RB to induce cell cycle arrest in normally resistant tumor cells. Interestingly, it has been reported that loss of hSNF5/INI1, a gene that encodes a BRG-1 like protein, occurs in malignant rhabdoid tumors (Versteege et al., 1998) . Although numerous mechanisms act upstream to inactivate RB (i.e. ampli®cations of Cyclin D1 or loss of p16ink4a) this report shows that the failure of down-stream signaling can also lead to functional inactivation of RB-mediated cell cycle inhibition.
Materials and methods
Cells, plasmids and transfection
SAOS-2 and C33A cells were maintained in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin-streptomycin and 2 mM L-glutamine at 378C in 5% CO 2 . C33A and SAOS-2 cells were passaged less than ten times. Plasmids were transfected using the calcium phosphate method previously described (Chen and Okayama, 1987) . The following plasmids: pH2B-GFP, pBabe-Puro, PSM-RB, p27kip1, Cyclin A, 3XE2FLuc, DHFRLuc, and -608CycA-Luc have also been previously described (Knudsen and Wang, 1997; Knudsen et al., 1998 Knudsen et al., , 1999a . The aryl hydrocarbon receptor (AHR) plasmid was provided by Dr Alvaro Puga (University of Cincinnati), and the BRG-1 expression plasmid was supplied by Dr Stephen P Go (Columbia University).
BrdU incorporation
Approximately 5610 5 C33A cells and 2.5610 5 SAOS-2 cells were seeded onto coverslips in each well of a 6-well dish. Twenty-four hours later the cells were transfected with 4 mg total DNA (as indicated). Forty-eight hours post-transfection the cells were labeled with BrdU to detect DNA synthesis. After 16 h of labeling the cells were ®xed in 3.7% formaldehyde in PBS for 15 min and then permeabilized in 0.3% Triton X-100 in PBS for 15 min. The cells were then probed with an anti-BrdU antibody (Accurate Scienti®c) at a 1 : 500 dilution in an Immuno¯uorescence buer (PBS, 5 mg/ ml BSA, 0.5% NP-40, 10 mM MgCl, 100 U/ml DNAse 1) for 1 h at 378C in a humidi®ed chamber. After washing the coverslips with PBS the cells were incubated with a rhodamine-conjugated secondary antibody in PBS supplemented with 5 mg/ml BSA and 0.5% NP-40, along with Hoechst for visualization of the nuclei. After 1 h of incubation the cells were washed in PBS and mounted onto slides. At least 100 transfected (GFP positive) and untransfected (GFP negative) cells were analysed from two to three independent experiments.
Reporter assays
Approximately 5610 5 C33A cells and 2.5610 5 SAOS-2 cells were plated into 6-cm dishes. Twenty-four hours later the cells were transfected (as indicated) with 8 mg of total plasmid DNA. Seventy-two hours post-transfection the cells were harvested. The Luciferase Assay System (Promega) was used to determine the luciferase activity of the transfected cells. Transfection eciency was determined by b-galactosidase activity and the relative luciferase activity shown was determined after its normalization to b-galactosidase activity. The data re¯ects the average of at least three independent experiments.
Immunoblotting and kinase reactions
Approximately 2610 6 C33A cells and 1610 6 SAOS-2 cells were plated in 10-cm dishes 24 h before transfection. Transfected C33A and SAOS-2 cells were selected posttransfection with 2.5 mg/ml puromycin (Sigma) for 48 h and then harvested for protein analysis or in vitro kinase assay. For immunoblotting, cells were trypsinized and then washed twice with PBS. The cell pellets were resuspended in RIPA buer containing protease inhibitors (10 mg/ml, 1,10 phenanthroline, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl¯uoride) and phosphatase inhibitors (10 mM sodium¯uoride, 0.1 mM sodium vanadate, and 60 mM b-glycerophosphate) for 15 min on ice. The lysates were brie¯y sonicated and centrifuged at 20 000 g for 10 min at 48C. The lysates were fractionated by SDS-polyacrylamide gel electrophoresis and then transferred onto Immobilon-P (Millipore). The membranes were then incubated with primary polyclonal antibodies: anti-Cdk2 (clone H-298, Santa Cruz), anti-Cyclin A (clone H-432, Santa Cruz), anti-Cyclin E (clone C-19, Santa Cruz), anti-Cdk4 (clone H-22, Santa Cruz), anti-p27kip1 (M-197, Santa Cruz), and anti-pRb (851, polyclonal antibody) (Welch and Wang, 1993) . The blots were then incubated with horseradish peroxidase conjugated goat anti-rabbit IgG (Biorad) for 1 h at room temperature. The antibody-antigen complex was detected by enhanced chemiluminescence procedure (ECL, Amersham Pharmacia Biotech). The kinase reactions were performed as previously described (Knudsen and Wang, 1996) , using 50 ± 100 mg of total cell lysate. The Cdk2 kinase complex was immunoprecipitated using anti-Cdk2 (clone H-298, Santa Cruz) antibodies and protein A-Sepharose (Pharmacia). The kinase complexes were then used to phosphorylate a histone H1 substrate. Reactions were separated by SDS-polyacrylamide gel electrophoresis and then transferred onto Immobilon-P membranes (Millipore). Incorporation of [g-32 P]ATP into histone H1 was detected by autoradiography; blots were then probed for Cdk2 using an anti-Cdk2 antibody (clone H-298, Santa Cruz). For antibody detection, protein A conjugated horseradish peroxidase (Biorad) was utilized at 1 : 2000 and visualized by ECL.
